Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia

¹ Psychiatric Center, Yokohama City University Medical Center, Yokohama, Japan and Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan.
² Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan and Yokohama Maioka Hospital, Yokohama, Japan.
³ Radioisotope Research Center, Yokohama City University School of Medicine, Yokohama, Japan.
⁴ Yokohama Maioka Hospital, Yokohama, Japan.
⁵ Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan.

^* To whom correspondence should be addressed.

	Abstract

Although treatment with antipsychotics, particularly olanzapine and clozapine, has been implicated in weight gain and higher incidence of diabetes, the mechanism of these adverse reactions remains unclear. The purposes of this study were to explore the early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin, three recently identified hormones that play crucial roles in the regulation of energy balance and glucose metabolism. Thirteen patients with schizophrenia who had not received any medication in the 4 weeks prior to this study were included. The patients received olanzapine at an average dose of 14.5 mg/day. Serum levels of ghrelin, adiponectin, leptin and insulin, as well as weight and fasting glucose, were investigated at the baseline and at 4 weeks. Serum ghrelin levels had decreased (p = 0.03) and leptin had increased (p = 0.02), while adiponectin and insulin levels had not significantly changed at Week 4 (p = 0.29 and p = 0.25, respectively). Weight had increased (p = 0.01), while fasting glucose had not significantly changed (p = 0.46). These findings suggest that ghrelin levels decrease and leptin levels increase after initiation of olanzapine therapy. Weight gain is also considered to be an early change, while change in insulin sensitivity is not an early change of treatment with olanzapine. Further large-scale and longitudinal studies are warranted to elucidate metabolic changes involving ghrelin, adiponectin, leptin and insulin and their impact on weight and glucose metabolism during treatment with olanzapine and other antipsychotics.

Key Words: olanzapine, schizophrenia, weight gain, diabetes, ghrelin, adiponectin, leptin

First published on October 4, 2005, doi:10.1177/0269881105056647

Journal of Psychopharmacology 2006;20:75.

A more recent version of this article appeared on January 1, 2006


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				O. Sentissi, J. Epelbaum, J.-P. Olie, and M.-F. Poirier Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review Schizophr Bull, November 1, 2008; 34(6): 1189 - 1199. [Abstract] [Full Text] [PDF]

				A. Sarandol, S. Kirli, C. Akkaya, N. Ocak, E. Eroz, and E. Sarandol Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment J Psychopharmacol, November 1, 2007; 21(8): 857 - 863. [Abstract] [PDF]

				N. R. Poa and P. F. Edgar Insulin Resistance Is Associated With Hypercortisolemia in Polynesian Patients Treated With Antipsychotic Medication Diabetes Care, June 1, 2007; 30(6): 1425 - 1429. [Abstract] [Full Text] [PDF]